Moelis & Company (MC) Bundle
You're looking at Moelis & Company (MC) right now and wondering if the M&A (Mergers and Acquisitions) market recovery is defintely real, and the short answer is yes, but it's still uneven-that's the core of the investment thesis going into the end of 2025. The firm reported a fantastic Q3 2025, with adjusted revenue jumping 34% year-over-year to $376.0 million, which pushed their first nine months of 2025 adjusted revenue past the $1.048 billion mark, a 37% increase from the prior year. This performance, driven by large strategic and sponsor-driven deals, translated directly to the bottom line, delivering an adjusted Earnings Per Share (EPS) of $0.68 for the quarter, handily beating analyst consensus. The balance sheet is rock-solid, showing $619.9 million in cash and no debt, which gives them serious flexibility to hire top talent and keep that quarterly dividend of $0.65 per share flowing. Still, the near-term risk is whether this M&A momentum broadens out to the middle-market, or if it remains concentrated in those big-ticket transactions, so we need to watch that closely for the full story.
Revenue Analysis
You need a clear picture of where Moelis & Company (MC) is making its money, and the 2025 numbers tell a story of a strong rebound in advisory work. The headline is this: Moelis & Company's revenue for the first nine months of 2025 hit an Adjusted total of $1,048.0 million, marking a 37% increase from the prior year period. That's a serious acceleration, driven by a recovering M&A market and higher fees per deal. Honestly, this is a firm that's firing on all cylinders in a favorable deal environment.
The firm is an independent investment bank, so its primary revenue stream is advisory fees-they don't have a large trading or lending arm to smooth out the bumps. This means their revenue is highly sensitive to the transaction cycle, specifically mergers and acquisitions (M&A), which is their bread and butter. The trailing twelve months (TTM) revenue ending September 30, 2025, was $1.47 billion, a massive 51.19% year-over-year growth, which defintely shows the market's appetite for complex, high-fee transactions is back.
Here's the quick math on the quarterly performance, showing the power of this upturn:
| Period (2025) | GAAP Revenue | YoY Growth (GAAP) | Adjusted Revenue |
|---|---|---|---|
| Q3 | $356.9 million | 30% | $376.0 million |
| Q2 | $365.4 million | 38% | N/A |
| Q1 | $307.0 million | 41% | N/A |
What this estimate hides is the nuance in their advisory segments. While the overall revenue is up, it's not a uniform rise across all their services. The firm's revenue is primarily composed of three main advisory areas, and their contributions are shifting.
- Mergers & Acquisitions (M&A): This is the core driver, seeing significant fee increases per completed deal.
- Capital Markets: Also a major growth engine, benefiting from renewed activity in equity and debt placements.
- Capital Structure Advisory: This segment, which includes restructuring, saw a decline in Q3 2025 compared to the prior year, partially offsetting the gains elsewhere.
The biggest change is the strategic investment in the Private Capital Advisory business, which is a clear pivot toward a high-growth area. Management is anticipating this segment alone could become a $200 million revenue opportunity as they expand their team and global footprint, especially in Europe. This focus on Private Capital Advisory and the expansion of Managing Directors in sectors like Technology and Business Services shows a deliberate strategy to diversify the revenue base beyond traditional M&A cycles. For a deeper dive into who is betting on this strategy, check out Exploring Moelis & Company (MC) Investor Profile: Who's Buying and Why?
Profitability Metrics
You want to know if Moelis & Company (MC) is actually making money, or if the recent revenue growth is just a flash in the pan. The direct takeaway is this: Moelis & Company's profitability has surged in 2025, driven by a rebound in deal flow and tight cost control, putting their net margin well ahead of a key peer like Lazard.
For the first nine months of 2025, Moelis & Company reported adjusted revenues of $1,048.0 million, a 37% increase from the prior year period. More importantly, this revenue growth is translating directly to the bottom line, which is what we want to see. The firm's adjusted net income for the same period was $158.8 million.
Gross, Operating, and Net Margins
Since Moelis & Company is an advisory firm, its cost of revenue is primarily compensation, resulting in an exceptionally high gross profit margin. For the first half of 2025, the gross profit margin stood at an impressive 92.43%. This is typical for a human-capital-intensive business where the main expense is operational, not cost of goods sold (COGS).
The real story is in the operating and net margins. The adjusted pre-tax margin, a close proxy for operating profit margin, was 18.2% for the first nine months of 2025. After taxes, the calculated net profit margin for the first nine months of 2025 sits at approximately 15.15% (calculated from $158.8 million net income / $1,048.0 million revenue). That's a strong number in this sector.
- Gross Margin (H1 2025): 92.43%
- Adjusted Pre-Tax Margin (9M 2025): 18.2%
- Net Profit Margin (9M 2025): 15.15%
Profitability Trends and Peer Comparison
The trend is defintely your friend here. Moelis & Company's profitability is not just rising; it's exploding off a low base. The firm's annual earnings growth is surging by 472.7%, a massive acceleration from its five-year average trend. This move is a clear sign of a cyclical rebound in M&A (Mergers and Acquisitions) and Capital Markets activity, where their independent advisory model shines.
When you compare this to a direct, publicly traded independent peer like Lazard, the strength becomes clearer. Lazard, for example, reported a much lower net profit margin of approximately 8.21% for the first half of 2025 (calculated from $116 million net income / $1,413 million adjusted revenue). Moelis & Company's 15.15% net margin nearly doubles that of Lazard's, showing superior conversion of revenue to profit in the near term.
Here's the quick math on the key margin ratios:
| Metric | Moelis & Company (9M 2025) | Peer Lazard (H1 2025) | Broader Advisory Median (2025) |
|---|---|---|---|
| Adjusted Net Revenue | $1,048.0 million | $1,413 million | N/A |
| Net Profit Margin | 15.15% (Calculated) | 8.21% (Calculated) | N/A |
| Operating Margin (Proxy) | 18.2% (Pre-Tax) | N/A | 27.8% |
Analysis of Operational Efficiency
The jump in profitability is underpinned by excellent cost management. For an investment bank, the compensation ratio is the single most critical metric of operational efficiency. In the second quarter of 2025, Moelis & Company successfully kept its compensation and benefits expense ratio at 69.0% of revenues. This is a healthy number for a boutique firm, signaling that new revenue is being generated efficiently without a proportional surge in the fixed cost base.
Also, non-compensation expenses-things like rent, technology, and travel-were tightly controlled at just 14.4% of revenues in Q2 2025. This balance, keeping the total operating expense ratio low while revenue soars, is what drives the high operating margin. It tells you the firm is using its recent investment in talent and platform to generate more fee income per professional. You can read more about how this is impacting the investor base at Exploring Moelis & Company (MC) Investor Profile: Who's Buying and Why?
Debt vs. Equity Structure
Moelis & Company (MC) operates with a remarkably conservative capital structure, prioritizing equity and cash over debt to finance its operations and growth. This is a critical factor for investors, as it signals financial resilience. While some financial data points to a total debt figure, the firm's core strategy is a no-long-term-debt approach, which is a major differentiator in the Capital Markets industry.
You're looking at a company that is defintely not chasing growth with high leverage. Instead, Moelis & Company relies on retained earnings and shareholder equity. As of the second quarter of 2025, the firm reported a strong liquidity position with $475 million in cash and liquid investments, and explicitly stated having no debt on its balance sheet.
- Cash and Liquid Investments (Q2 2025): $475 million
- Long-Term Debt (June 30, 2025): $0M
- Total Debt (June 2025): $218.82 million
Debt-to-Equity: A Closer Look at Leverage
The headline for Moelis & Company's financing is its minimal reliance on external borrowing. The $218.82 million in total debt reported around mid-2025 is effectively short-term operating liabilities, not long-term structural financing, since their long-term debt is $0M. This distinction is vital.
Here's the quick math on their leverage: Moelis & Company's Total Debt to Equity ratio for the most recent quarter (MRQ) ending October 2025 was approximately 43.28%. This is slightly higher than the peer-group industry average of 38.39% for that same period, but still well within a healthy range, especially for a firm that has $0 in long-term debt. The broader Capital Markets industry average is a Debt-to-Equity ratio of 0.53 (or 53%), so Moelis & Company is operating with less leverage than the general industry benchmark. They are simply not financially constrained by debt service.
| Metric | Moelis & Company (MC) (MRQ 2025) | Industry Average (MRQ 2025) |
|---|---|---|
| Total Debt to Equity Ratio | 43.28% | 38.39% |
| Long-Term Debt | $0M | N/A |
Financing Strategy: Equity-Funded Growth
Moelis & Company's strategy is clear: fund growth through equity and retained earnings, avoiding the fixed cost and risk of long-term debt. This is why you won't see recent news of large debt issuances, credit ratings, or refinancing activity for their core business-there's simply no debt to rate or refinance. This model gives them maximum flexibility to navigate market downturns, which is a significant competitive advantage in the cyclical investment banking space.
Their focus remains on using their strong cash position to invest in high-growth areas, like the Private Capital Advisory business, which they see as a potential $200 million revenue opportunity. They also return capital to shareholders via dividends, such as the regular quarterly dividend of $0.65 per share declared in Q1 and Q2 2025. This cash-rich, debt-free approach is a core part of their investment thesis. You can learn more about who is investing in this model by Exploring Moelis & Company (MC) Investor Profile: Who's Buying and Why?
Liquidity and Solvency
You're looking for a clear signal of financial stability, and Moelis & Company (MC) delivers a strong one: their liquidity position is excellent, anchored by substantial cash reserves and, critically, no funded debt as of the end of the third quarter of 2025. This debt-free balance sheet gives them significant operational flexibility, especially in volatile markets.
As a seasoned financial analyst, I look at the current and quick ratios (liquidity positions) to gauge a firm's ability to cover its near-term obligations. For Moelis & Company, the two ratios are nearly identical, which is typical for a pure-play investment bank with virtually no inventory.
- Current Ratio (Q3 2025): 1.29
- Quick Ratio (Q3 2025): 1.29
Here's the quick math: based on the September 30, 2025, balance sheet, Total Current Assets were approximately $422 million and Total Current Liabilities were $328 million. A ratio of 1.29 means the firm has $1.29 in liquid assets for every $1.00 of short-term debt. This is a very comfortable cushion, showing they can easily meet immediate liabilities.
Working Capital and Cash Flow Trends
The strength is also visible in their working capital (Current Assets minus Current Liabilities), which stood at a positive $94 million in Q3 2025. This positive trend is a direct result of strong revenue growth-Adjusted Revenues for the first nine months of 2025 were $1,048.0 million, an increase of 37% from the prior year period. The firm is growing its top line and keeping its short-term finances well-managed.
The cash flow statement overview for the Trailing Twelve Months (TTM) ending Q3 2025 reveals a healthy cycle of cash generation and strategic deployment. Operating activities are the engine of the business, and they are performing well.
| Cash Flow Component (TTM Q3 2025) | Amount (in millions USD) | Analysis |
|---|---|---|
| Operating Cash Flow | $552.9 | Strong cash generation from core advisory services. |
| Investing Cash Flow | -$182.6 | Outflow indicates strategic investments, likely in technology, new hires, or office expansion. |
| Financing Cash Flow | -$231.4 | Outflow is primarily due to dividend payments ($0.65 per share quarterly) and share repurchases, returning capital to shareholders. |
The positive Operating Cash Flow of $552.9 million is more than enough to cover the capital expenditures (Investing Cash Flow) and the significant capital returns to shareholders (Financing Cash Flow). This is defintely a marker of a mature, cash-rich business model.
Liquidity Strengths and Actionable Insight
The primary strength is the sheer amount of ready cash. Moelis & Company reported holding cash and liquid investments of $619.9 million as of September 30, 2025. That's a massive war chest for a firm of its size. The firm uses this liquidity to fund its growth initiatives, like aggressively scaling its Private Capital Advisory business, and for capital returns, including a regular quarterly dividend of $0.65 per share.
What this estimate hides is the potential for a large, one-time compensation payout at the end of the fiscal year, which is typical for investment banks, but the current cash position suggests they are well-prepared. Still, the overall picture is one of exceptional financial health and a strong capacity to weather any near-term market slowdowns. You can read more about the firm's strategic focus here: Mission Statement, Vision, & Core Values of Moelis & Company (MC).
Next Step: Portfolio Manager: Confirm the firm's projected full-year 2025 compensation expense ratio (which was 69% in Q2 2025) against available cash to stress-test the year-end liquidity.
Valuation Analysis
You're looking at Moelis & Company (MC) and trying to figure out if the current price makes sense, and honestly, the valuation metrics suggest the market is holding its breath. The stock isn't cheap, but it's not wildly overvalued either, sitting right in the middle of a cyclical industry shift.
Based on 2025 fiscal year estimates, the forward Price-to-Earnings (P/E) ratio-a measure of what you're paying for each dollar of expected earnings-is around 20.81. That's a premium to the broader financial sector, but investment banks often carry higher P/E ratios when M&A activity is expected to pick up. For a more asset-light view, the Price-to-Book (P/B) ratio is high at approximately 8.76, which is typical for a pure-play advisory firm where the value is in the people, not the physical assets.
Here's the quick math on the enterprise value: The Enterprise Value-to-EBITDA (EV/EBITDA) is a bit stretched at approximately 27.9x (based on December 2024 figures), reflecting a significant multiple on its operating profit before non-cash charges. This suggests investors are pricing in a strong recovery in advisory fees.
- Forward P/E Ratio: 20.81 (2025 Est.)
- Price-to-Book (P/B) Ratio: 8.76
- EV/EBITDA Ratio: 27.9x (Dec 2024)
Stock Performance and Analyst Sentiment
The last 12 months have been a rollercoaster for Moelis & Company (MC). The stock price fell by 15.18% over the period, which is a clear signal of the market's reaction to the slower deal-making environment. Still, it's trading well off its 52-week low of $47.00, but substantially below the 52-week high of $82.89. The all-time high of $81.20 was actually hit earlier this year, on February 6, 2025, so the volatility is real.
The dividend story is compelling, but you need to watch the sustainability. Moelis & Company pays an annual dividend of approximately $2.60 per share, resulting in an attractive dividend yield of about 3.98% to 4.10%. But, the payout ratio is high, sitting in the range of 80.2% to 87% of earnings. That's a high percentage of net income going out, so any dip in earnings could force a dividend cut. It's defintely a risk to map.
Wall Street's consensus is cautious. Out of 11 analysts covering the stock, the majority recommend a 'Hold' rating (7 Holds, 3 Buys, 1 Strong Buy). The average 12-month price target is $71.57, suggesting a modest upside from the current price around $63.35. What this estimate hides is the potential for a massive upside if the M&A market truly re-accelerates, but the current 'Hold' signals a wait-and-see approach until that recovery is concrete. For a deeper dive into the firm's operational strengths and weaknesses, you should read our full analysis: Breaking Down Moelis & Company (MC) Financial Health: Key Insights for Investors.
Risk Factors
You are looking at Moelis & Company (MC) after a strong run, but remember that independent advisory is a fundamentally cyclical business. Your biggest risks aren't about a shaky balance sheet-Moelis & Company (MC) has a strong cash position of $619.9 million and no debt as of Q3 2025. The real threats are macro, operational, and tied directly to the global M&A (Mergers and Acquisitions) environment. You need to map these external pressures to the firm's specific vulnerabilities.
The primary external risk is market volatility, which directly chokes off deal flow. When CEOs lack clarity on interest rates, inflation, or geopolitical conflict-like the kind causing global trade disputes-they put M&A on hold. This is why the investment banking sector as a whole faces a challenge: earnings growth must now do more heavy lifting, since half of recent returns were driven by simple valuation expansion.
Here are the near-term external headwinds you should monitor:
- Geopolitical Risk: Heightened tensions increase the risk of cyberattacks and cause market fluctuations, impacting asset prices and investment portfolios.
- Regulatory Changes: The scheduled implementation of Basel III changes on July 1, 2025, is designed to modify criteria for credit risk and operational risk, which means stricter compliance and governance for the firm.
- Interest Rate/Inflation Uncertainty: Despite a softening outlook, inflation could regain prominence, significantly altering expectations for interest rates and asset classes across the board.
On the operational side, the risk is about concentration and talent. Moelis & Company (MC) is a people-driven business; the loss of a key Managing Director (MD) can immediately impact deal pipeline and revenue. This makes the compensation expense ratio of about 69% (Q2 2025) a critical figure-it shows the firm is defintely paying up to retain top talent.
Also, while overall revenue is up, you saw a specific challenge in the Capital Structure Advisory segment, which declined in Q3 2025. This advisory work is a crucial counter-cyclical hedge, so weakness here is a concern, even as M&A and Capital Markets fees drive the Q3 adjusted revenue to $376.0 million.
Here's the quick math on the firm's recent performance versus its operational cost structure:
| Metric | Value (Q3 2025) | Risk/Mitigation Context |
|---|---|---|
| Adjusted Revenue | $376.0 million | Driven by M&A/Capital Markets strength. |
| Adjusted Pre-Tax Margin | 22.2% | Strong improvement from 9.5% in the prior year period, showing cost control. |
| Compensation Expense Ratio | ~69% (Q2 2025) | High ratio reflects reliance on and cost of top talent. |
| Capital Structure Advisory | Declined in Q3 2025 | Operational risk; counter-cyclical business is not fully offsetting. |
The mitigation strategy is clear: Moelis & Company (MC) is going on offense. They are investing heavily in high-growth, recurring revenue areas like Private Capital Advisory, which they see as a potential $200 million revenue opportunity. They are also strategically hiring MDs in Technology and Private Capital Advisory to diversify their client base and expand their deal pipeline. This focus on talent and expansion is their best defense against cyclical downturns and competition. For a deeper look at the firm's investor base, check out Exploring Moelis & Company (MC) Investor Profile: Who's Buying and Why?
Growth Opportunities
You're looking for a clear map of where Moelis & Company (MC) goes from here, and the answer is simple: they are betting big on the M&A cycle turning and aggressively building out a new, high-growth revenue stream. The firm is positioned to capitalize on a long-anticipated rebound in dealmaking thanks to a deliberate, multi-year investment in talent and a strategic push into Private Capital Advisory (PCA).
This isn't just wishful thinking; the 2025 numbers already show momentum. For the first nine months of 2025, Moelis & Company reported adjusted revenues of over $1,048.0 million, a 37% increase compared to the prior year period. That's a powerful surge, and analysts project the firm's revenue will grow at 14.4% per year, which is comfortably ahead of the US market forecast of 10.3%. They are defintely moving into the next cycle with speed.
Key Growth Drivers and Strategic Expansion
Moelis & Company's growth isn't reliant on a single product. It's a combination of cyclical recovery and targeted expansion. The biggest near-term opportunity is the anticipated pickup in sponsor activity-that is, private equity firms getting back to buying and selling after a slowdown. Management has stated the M&A pipeline is currently sitting near record levels, which suggests a strong second half of 2025 and beyond.
The core strategic initiative, however, is the aggressive expansion of their Private Capital Advisory (PCA) platform. This business, which advises on private fund transactions, is being scaled up to be a 'third or fourth leg' of the firm's revenue base, aiming for market leadership. This diversification is smart because it provides a steadier stream of fee income, helping to smooth out the volatility inherent in event-driven M&A revenue.
- M&A Cycle Rebound: Improving deal conversion rates and increased sponsor activity.
- PCA Platform: Aggressive scaling of Private Capital Advisory for new, stable revenue.
- Talent Investment: Strategic hiring of new Managing Directors in key sectors like Technology and Capital Markets.
- Leadership Transition: Navid Mahmoodzadegan's move to CEO, with Ken Moelis as Executive Chairman, ensures continuity and a focus on future growth.
Future Projections and Competitive Edge
Looking at the full fiscal year 2025, the consensus revenue estimate is $1.28 billion, with earnings expected to be $1.77 per share. Here's the quick math on why that growth is sustainable: Moelis & Company has a distinct competitive advantage in its independent advisory model. Unlike bulge bracket banks like JPMorgan Chase or Goldman Sachs, Moelis & Company focuses purely on advisory services, meaning their advice is free from the conflicts of interest associated with lending or underwriting activities.
Plus, they have a globally integrated platform with over 20 locations worldwide and a deep bench of experienced professionals, particularly in complex transactions and restructuring advisory. This expertise is crucial in a volatile market. To be fair, talent retention is a constant challenge in this industry, but the firm's strong balance sheet, which boasts $619.9 million in cash and short-term investments and no debt as of Q3 2025, gives them the financial firepower to attract and retain top bankers.
What this estimate hides is the potential for a significant upside surprise if the M&A market accelerates faster than expected. The firm is built to handle that volume. Here is a snapshot of their financial strength and growth trajectory:
| Metric | Value/Estimate (FY 2025) | Source/Context |
|---|---|---|
| Adjusted Revenue (9 Mos. 2025) | $1,048.0 million | 37% Y/Y increase. |
| Full-Year Revenue Estimate | $1.28 billion | Consensus estimate as of July 2025. |
| EPS Estimate (Full-Year) | $1.77 per share | Consensus estimate as of July 2025. |
| Cash & Short-Term Investments (Q3 2025) | $619.9 million | Strong balance sheet, no debt. |
To understand the firm's culture driving this growth, you should review their Mission Statement, Vision, & Core Values of Moelis & Company (MC).
Next Step: Portfolio Managers should model a scenario where Moelis & Company's 2025 revenue exceeds the $1.28 billion consensus by 10% to account for the near-record pipeline and aggressive PCA expansion, then adjust your price target accordingly.

Moelis & Company (MC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.